Limosilactobacillus reuteri ATCC PTA 5289 and DSM 17938 as adjuvants to improve evolution of pharyngitis/tonsillitis in children: randomised controlled trial
Open Access
- 12 April 2021
- journal article
- research article
- Published by Brill in Beneficial Microbes
- Vol. 12 (2), 137-145
- https://doi.org/10.3920/bm2020.0171
Abstract
Pharyngitis and tonsillitis are the most common acute respiratory infections (ARIs) in children aged ≤5 years. The analysis of published data showed that some probiotics could decrease the frequency and number of days with ARIs. This study evaluated the safety and efficacy of Limosilactobacillus reuteri ATCC PTA 5289 and DSM 17938 to reduce the duration and severity of ARI symptoms. This randomised controlled trial included children aged from 6 months to 5 years, with pharyngitis or tonsillitis, who were randomised to receive a probiotic product containing L. reuteri ATCC PTA 5289 and L. reuteri DSM 17938 or placebo, as drops, ingested orally for 10 days as adjuvants to the use of non-steroidal anti-inflammatory drugs. The main outcomes were the duration and severity of ARI symptoms. The secondary outcomes were changes in salivary immunoglobulin A and inflammatory biomarkers. There was no fever on day 2 and subsequent days in the L. reuteri group (37.3 ±0.5 °C vs 38.6±0.3 °C, PPL. reuteri group. Significant differences in the days with runny nose, nasal congestion, days of non-programmed visits to the medical office or emergency department, levels in tumoral necrosis factor-alpha (TNF-alpha) and related costs of treatment were observed in the L. reuteri group. The frequency of adverse events was similar between the groups. Therefore, L. reuteri ATCC PTA 5289 combined with L. reuteri DSM 17938 is a safe and effective adjunct to reduce the symptoms of pharyngitis or tonsillitis in children.Keywords
This publication has 30 references indexed in Scilit:
- Randomized Trial of Probiotics and Calcium on Diarrhea and Respiratory Tract Infections in Indonesian ChildrenPEDIATRICS, 2012
- Interventions to Influence Consulting and Antibiotic Use for Acute Respiratory Tract Infections in Children: A Systematic Review and Meta-AnalysisPLOS ONE, 2012
- Prevalence of Streptococcal Pharyngitis and Streptococcal Carriage in Children: A Meta-analysisPEDIATRICS, 2010
- Pragmatic Scoring System for Pharyngitis in Low-Resource SettingsPEDIATRICS, 2010
- Probiotic Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory factorsBMC Microbiology, 2009
- Removal of Antibiotic Resistance Gene-Carrying Plasmids from Lactobacillus reuteri ATCC 55730 and Characterization of the Resulting Daughter Strain, L . reuteri DSM 17938Applied and Environmental Microbiology, 2008
- Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogensAnaerobe, 2008
- Viral Upper Respiratory Tract Infection and Otitis Media Complication in Young ChildrenClinical Infectious Diseases, 2008
- Protective effect of antibiotics against serious complications of common respiratory tract infections: retrospective cohort study with the UK General Practice Research DatabaseBMJ, 2007
- Systemic antibiotic treatment in upper and lower respiratory tract infections: official French guidelinesClinical Microbiology & Infection, 2003